Germany / Saudi Arabia / Italy / Turkey / United States / Greece / India / / /
Event
Business Partnership / /
Facility
Blood Institute / /
IndustryTerm
treatment of patients with sickle cell disease / treatment of this disease / public insurance / potential solutions / care for patients with sickle cell disease / treatment of sickle cell disease / Treatment for Sickle Cell Disease / care of this disease / health systems / treatment for patients who have sickle cell disease / /
National Institute of Health / The Johns Hopkins University / office of Medical Applications of Research of the National Institutes of Health / NATIONAL INSTITUTES OF HEALTH office of the Director About / National Heart / Lung / and Blood Institute / NIH Consensus Development Program Information Center / federal government / Johns Hopkins University Evidence-Based Practice Center / U.S. Food and Drug Administration / NATIONAL INSTITUTES OF HEALTH office / Agency for Healthcare Research and Quality / /
Person
Ann Intern / / /
Position
Hb / public representative / principal physician / Governor / Director / /
NIH State-of-the-Science Conference Statement on Hydroxyurea Treatment for Sickle Cell Disease NIH Consensus and State-of-the-Science Statements Volume 25, Number 1